Showing results (351-360 of 432) with videos related to
Sort By:
Pageof 44
European Neurology|March 31, 1998
White matter changes on CT and MRI: an overview of visual rating scales. European Task Force on Age-Related White Matter ChangesP Scheltens, T Erkinjunti, D Leys, et al.Annals of Neurology|October 1, 1992
Familial adult-onset muscular dystrophy with leukoencephalopathyB G van Engelen, Q H Leyten, P L Bernsen, et al.Journal of Neurology, Neurosurgery, and Psychiatry|November 13, 2013
Long-term impact of interferon beta-1b in patients with CIS: 8-year follow-up of BENEFITG Edan, L Kappos, X Montalbán, et al.AJNR. American Journal of Neuroradiology|March 23, 2006
Cerebral white matter abnormalities in 6p25 deletion syndromeM S van der Knaap, M Kriek, W C G Overweg-Plandsoen, et al.Neurology|March 17, 1999
Primary and transitional progressive MS: a clinical and MRI cross-sectional studyV L Stevenson, D H Miller, M Rovaris, et al.Alzheimer'S Research & Therapy|May 28, 2026
T1-weighted/T2-weighted ratio reflects microstructural changes in Alzheimer's diseaseN Reijner, M Riscado Ramos, E Jacobs, et al.Journal of Neurology, Neurosurgery, and Psychiatry|July 15, 2010
T2 lesion location really matters: a 10 year follow-up study in primary progressive multiple sclerosisB Bodini, M Battaglini, N De Stefano, et al.European Journal of Neurology|January 11, 2019
Predicting clinical progression in multiple sclerosis after 6 and 12 yearsI Dekker, A J C Eijlers, V Popescu, et al.Neurology|September 23, 2009
Baseline CSF p-tau levels independently predict progression of hippocampal atrophy in Alzheimer diseaseW J P Henneman, H Vrenken, J Barnes, et al.Annals of Neurology|June 9, 1999
Decreased interleukin-10 and increased interleukin-12p40 mRNA are associated with disease activity and characterize different disease stages in multiple sclerosisA H van Boxel-Dezaire, S C Hoff, B W van Oosten, et al.Pageof 44